Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alzheimer's PET Imaging in Diverse Adults
NCT03706261Phase 1Completed
- Start
- Mar 2019
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial. Primary endpoints: Regional Standardized Uptake Value Ratio for 18F-MK-6240 at 1 day and Number of Participants With Amyloid Positivity (Aβ+) for 18F-Florbetaben at 1 day. Started Mar 2019; status: completed.
Beyond the preview
Go deeper on NCT03706261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03706261.